VSEE vs. MRAI, BRTX, KDLY, MGRX, OTRK, SSY, ATPC, ACON, ATIP, and BGLC
Should you be buying Vsee Health stock or one of its competitors? The main competitors of Vsee Health include Marpai (MRAI), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Mangoceuticals (MGRX), Ontrak (OTRK), SunLink Health Systems (SSY), Agape ATP (ATPC), Aclarion (ACON), ATI Physical Therapy (ATIP), and BioNexus Gene Lab (BGLC). These companies are all part of the "healthcare" industry.
Vsee Health vs.
Marpai (NASDAQ:MRAI) and Vsee Health (NASDAQ:VSEE) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, community ranking, media sentiment and dividends.
Vsee Health has a consensus target price of $5.00, indicating a potential upside of 327.35%. Given Vsee Health's stronger consensus rating and higher possible upside, analysts plainly believe Vsee Health is more favorable than Marpai.
Vsee Health has lower revenue, but higher earnings than Marpai.
Marpai and Vsee Health both received 2 outperform votes by MarketBeat users. However, 100.00% of users gave Vsee Health an outperform vote while only 66.67% of users gave Marpai an outperform vote.
49.8% of Marpai shares are owned by institutional investors. Comparatively, 1.0% of Vsee Health shares are owned by institutional investors. 61.3% of Marpai shares are owned by company insiders. Comparatively, 6.6% of Vsee Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
In the previous week, Vsee Health had 2 more articles in the media than Marpai. MarketBeat recorded 3 mentions for Vsee Health and 1 mentions for Marpai. Vsee Health's average media sentiment score of 0.34 beat Marpai's score of 0.00 indicating that Vsee Health is being referred to more favorably in the news media.
Vsee Health has a net margin of 0.00% compared to Marpai's net margin of -85.70%. Marpai's return on equity of 0.00% beat Vsee Health's return on equity.
Summary
Vsee Health beats Marpai on 10 of the 14 factors compared between the two stocks.
Get Vsee Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for VSEE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vsee Health Competitors List
Related Companies and Tools
This page (NASDAQ:VSEE) was last updated on 4/22/2025 by MarketBeat.com Staff
Buy VSEE Stock Free VSEE Stock Alerts